Tool
Supplement comparison tool
Pick up to 4 knowledge base entries and compare their dosage, price, evidence strength and ratings side by side — you can save or share a link to your selection.
Add to comparison (2/4)
| Category | Długowieczność | Długowieczność |
| Evidence strength | Early-stage evidence | Moderate evidence |
| Evidence Score | 2/5 | 3/5 |
| User rating | 4.0 (21) | 4.3 (38) |
| Typical dose | — | — |
| Form | — | — |
| Average price | — | — |
| Monthly cost | — | — |
| Time to effects | No human data — in mouse studies, effects were observed after a period of regular administration within the experiment, but no human interventional trials have been conducted yet. | This is a process that builds up gradually over decades, not a phenomenon with a single point of onset — increased inflammaging is measurable in population studies as early as middle age, with a marked acceleration after age 60. |
| Who it's for | People following frontier research on the biology of aging and the role of the gut microbiome | People interested in the mechanisms linking chronic inflammation to diseases of old age |